What is the share price of Soni Medicare Ltd (SML) today?
The share price of SML as on 24th August 2026 is ₹69.35. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Soni Medicare Ltd (SML) share?
The past returns of Soni Medicare Ltd (SML) share are- Past 1 week: N/A%
- Past 1 month: N/A%
- Past 3 months: -3.55%
- Past 6 months: 16.42%
- Past 1 year: -10.91%
- Past 3 years: 158.87%
- Past 5 years: 127.38%
What are the peers or stocks similar to Soni Medicare Ltd (SML)?
The peers or stocks similar to Soni Medicare Ltd (SML) include:What is the market cap of Soni Medicare Ltd (SML) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Soni Medicare Ltd (SML) is ₹31.13 Cr as of 24th August 2026.What is the 52 week high and low of Soni Medicare Ltd (SML) share?
The 52-week high of Soni Medicare Ltd (SML) is ₹114.15 and the 52-week low is ₹43.82.What is the PE and PB ratio of Soni Medicare Ltd (SML) stock?
The P/E (price-to-earnings) ratio of Soni Medicare Ltd (SML) is -11.49. The P/B (price-to-book) ratio is 24.13.Which sector does Soni Medicare Ltd (SML) belong to?
Soni Medicare Ltd (SML) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Soni Medicare Ltd (SML) shares?
You can directly buy Soni Medicare Ltd (SML) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Soni Medicare Ltd
SML Share Price
BSE₹69.354.99% (-3.64)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SML Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
SML Performance & Key Metrics
SML Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -8.58 | 24.13 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
SML Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SML Company Profile
Soni Medicare operates multi-specialty hospital in Jaipur
APOLLOHOSP
PE Ratio
66.23
66.23
1Y Return
13.94%
13.94%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
70.80
70.80
1Y Return
10.58%
10.58%
Buy Reco %
83.33
83.33
MANIPALHOS
PE Ratio
108.93
108.93
1Y Return
10.80%
10.80%
Buy Reco %
62.50
62.50
FORTIS
PE Ratio
64.21
64.21
1Y Return
8.51%
8.51%
Buy Reco %
90.00
90.00
PE Ratio
169.57
169.57
1Y Return
22.99%
22.99%
Buy Reco %
90.91
90.91
SML Forecast
SML Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SML
SML
Income
Balance Sheet
Cash Flow
Quarterly Normal View
SML Income Statement
SML Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7.15 | 7.28 | 8.60 | 7.79 | 7.52 | 7.49 | 6.52 | 5.65 | 6.58 | 4.78 | ||||||||||
Operating & Other expenses | 7.61 | 7.84 | 7.73 | 7.53 | 6.82 | 7.40 | 7.04 | 6.32 | 6.40 | 5.44 | ||||||||||
EBITDA | -0.46 | -0.56 | 0.87 | 0.26 | 0.70 | 0.09 | -0.52 | -0.67 | 0.18 | -0.66 | ||||||||||
| Depreciation/Amortization | 0.13 | 0.12 | 0.11 | 0.12 | 0.15 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | ||||||||||
| PBIT | -0.59 | -0.68 | 0.76 | 0.14 | 0.55 | -0.04 | -0.65 | -0.80 | 0.05 | -0.79 | ||||||||||
| Interest & Other Items | 0.28 | 0.18 | 0.28 | 0.24 | 0.29 | 0.25 | 0.27 | 0.34 | 0.36 | 0.39 | ||||||||||
| PBT | -0.87 | -0.86 | 0.48 | -0.10 | 0.26 | -0.29 | -0.92 | -1.14 | -0.31 | -1.18 | ||||||||||
| Taxes & Other Items | 0.02 | 0.01 | 0.01 | 0.03 | -0.09 | 0.00 | 0.01 | 0.00 | 0.06 | 0.01 | ||||||||||
| Net Income | -0.89 | -0.87 | 0.47 | -0.13 | 0.35 | -0.29 | -0.93 | -1.14 | -0.37 | -1.19 | ||||||||||
| EPS | -2.10 | -2.03 | 1.09 | -0.31 | 0.51 | -0.68 | -2.16 | -2.65 | -0.45 | -2.81 |
SML Company Updates
SML Stock Peers
SML Past Performance & Peer Comparison
SML Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Soni Medicare Ltd | -11.49 | 24.13 | — |
| Apollo Hospitals Enterprise Limited | 66.23 | 12.89 | 0.22% |
| Max Healthcare Institute Limited | 70.80 | 9.50 | 0.19% |
| Manipal Health Enterprises Limited | 108.93 | 11.05 | — |
SML Stock Price Comparison
Compare SML with any stock or ETFCompare SML with any stock or ETF
SML
SML Holdings
SML Shareholdings
SML Promoter Holdings Trend
SML Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SML Institutional Holdings Trend
SML Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SML Shareholding Pattern
SML Shareholding Pattern
SML Shareholding History
SML Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SML stock
smallcases containing SML stock
Looks like this stock is not in any smallcase yet.
SML Events
SML Events
SML Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SML has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SML Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SML has not given any dividends in last 5 years
SML Dividends
SML Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSML Stock News & Opinions
SML Stock News & Opinions
Articles & Videos
Corporate
Corporate
Soni Medicare Limited’s 38th Annual General Meeting is scheduled for September 29, 2025, in JaipurSoni Medicare Limited will hold its 38th Annual General Meeting on September 29, 2025, at 3:00 P.M. in Jaipur, and the company’s register of members and share transfer books will be closed from September 23, 2026, to September 29, 2026, with September 22, 2026, set as the cut-off date for e-voting eligibility, and remote e-voting commencing on September 26, 2026, and ending on September 28, 2026.
1 week agoCapital Market - Live
Corporate
Corporate
Soni Medicare’s board approved financial report and scheduled AGM for September 29 in JaipurSoni Medicare Limited informed the BSE Limited that its board of directors approved the board report for the financial year ended March 31, 2026, and convened the 38th Annual General Meeting for September 29, 2026, at 38, Kanota Bagh, Jawaharlal Nehru Marg, Jaipur. The company also appointed M/s. Mahendra Khandelwal & Company as the scrutinizer for the AGM, approved changes in designations for Mr. Namit Soni and Mr. Lavi Kumar Mutha, and approved increases in limits under sections 186 and 185 of the Companies Act, 2013, up to Rs 100 crores in each case, all subject to member approval.
2 weeks agoCapital Market - Live
Corporate
Corporate
Soni Medicare appoints Namit Soni as Additional Executive Director through August 2026Soni Medicare Limited announced the appointment of Mr. Namit Soni as Additional Executive Director, effective August 14, 2026, and continuing until the company's next Annual General Meeting. Mr. Soni, whose appointment was approved by the board on Friday, August 14, 2026, holds a degree from St. Stephens’ College and an MBA from IMI, New Delhi, and is the son of Chairman and MD Mr. Bimal Roy Soni and Non-Executive Director Mrs. Anju Soni.
1 month agoCapital Market - Live
Earnings
Earnings
Soni Medicare reports standalone net loss of Rs 0.37 crore in the March 2026 quarterNet loss of Soni Medicare reported to Rs 0.37 crore in the quarter ended March 2026 as against net profit of Rs 0.35 crore during the previous quarter ended March 2025. Sales declined 15.14% to Rs 5.83 crore in the quarter ended March 2026 as against Rs 6.87 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 2.71 crore in the year ended March 2026 as against net loss of Rs 0.19 crore during the previous year ended March 2025. Sales declined 17.19% to Rs 24.71 crore in the year ended March 2026 as against Rs 29.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales5.836.87 -15 24.7129.84 -17 OPM %3.0910.19 --3.684.22 - PBDT-0.180.41 PL -2.130.27 PL PBT-0.310.26 PL -2.64-0.23 -1048 NP-0.370.35 PL -2.71-0.19 -1326 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare to discuss resultsSoni Medicare will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Soni Medicare reports standalone net loss of Rs 1.13 crore in the December 2025 quarterNet Loss of Soni Medicare reported to Rs 1.13 crore in the quarter ended December 2025 as against net loss of Rs 0.13 crore during the previous quarter ended December 2024. Sales declined 28.72% to Rs 5.36 crore in the quarter ended December 2025 as against Rs 7.52 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales5.367.52 -29 OPM %-12.313.46 - PBDT-1.000.02 PL PBT-1.13-0.10 -1030 NP-1.13-0.13 -769 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare schedules board meetingSoni Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Soni Medicare reports standalone net loss of Rs 0.92 crore in the September 2025 quarterNet loss of Soni Medicare reported to Rs 0.92 crore in the quarter ended September 2025 as against net profit of Rs 0.47 crore during the previous quarter ended September 2024. Sales declined 25.48% to Rs 6.23 crore in the quarter ended September 2025 as against Rs 8.36 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales6.238.36 -25 OPM %-8.1910.41 - PBDT-0.780.59 PL PBT-0.910.48 PL NP-0.920.47 PL Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare to table resultsSoni Medicare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare to convene AGMSoni Medicare announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.33%, vs industry avg of 18.03%
Over the last 5 years, market share decreased from 0.04% to 0.03%